olivlawolivlaw

olivLaw · European equity research

Synthomer plc SYNT.L

United Kingdom · London Stock Exchange · ISIN GB00BNTVWJ75 · Vertical: Listed companies from United Kingdom

1.09GBP−0.73% · 1 dayClose 05 Nov 2026

Synthomer is a speciality chemicals producer supplying water-based polymers and ingredients to business customers in coatings, construction, adhesives and health markets. The company is working through weak demand, but its specialisation strategy and cost programmes have lifted margins and cash flow, while debt remains a central focus, with revenue of £1,739.2m and net debt of £575.0m in fiscal 2025.

At the close of 05 Nov 2026, Synthomer plc (SYNT.L) stock was 1.09 GBP (−0.73% on the day), with market capitalisation 178.6 m GBP, dividend yield 0.00%, beta 1.08, 52-week range 0.18–1.22 GBP.

Data as of · AI analysis dated · Source: ESEF annual reports and closing prices, computed by olivLaw.

Market cap
178.6 m GBP
shares as of 31 Dec 2025
P/E (TTM)
unavailable
Diluted EPS TTM -0.96 · TTM to 31 Dec 2025
E/P (TTM)
-87.91%
TTM to 31 Dec 2025
Dividend yield
0.00%
DPS 12m 0.00
Beta (2y)
1.08
Volatility (1y) 123%
52-week range
0.181.22

Price history

Loading chart…

Technical reading

RSI (14)
47.6
neutral
Bollinger (20, 2)
1.05 – 1.20
in the lower half of the band · %B 0.28 · band width 13.9%
SMA 50 / 200
1.09 / 0.79
uptrend (price > SMA50 > SMA200)
MACD (12, 26, 9)
0.01 / 0.02
MACD below signal

Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).

Performance

CompanyEURO STOXX 50vs EURO STOXX 50Vertical median
1 month+1.5%−0.6%+2.1 pp—
3 months−7.1%−4.2%−3.0 pp—
6 months+3.6%+4.3%−0.7 pp—
Year to date+72.5%+7.5%+65.0 pp—
1 year+126.3%+9.9%+116.4 pp+5.8%
3 years−47.0%+49.8%−96.8 pp+26.3%
5 years−97.1%+42.8%−139.9 pp—
Max drawdown (1y)
−72.4%
30 Dec 2025 → 03 Mar 2026
Max drawdown (5y)
−99.5%
22 Nov 2021 → 03 Mar 2026
Compound annual growth (5y)
−50.7%
EURO STOXX 50 +7.4%

Price returns, dividends excluded.

Quarterly results

ESEF annual reports carry no quarters: the results are annual (below).

E/P over time

E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.

Fiscal years

Fiscal year202320242025
Revenue1.9 bn1.9 bn1.7 bn
Revenue YoYunavailable−0.4%−10.0%
Net income-67.0 m-72.6 m-157.0 m
Net income YoYunavailableunavailableunavailable
Diluted EPS-0.79-0.44-0.96
Diluted EPS YoYunavailableunavailableunavailable
net %-3.5%-3.8%-9.0%
Free cash flow66.0 m-124.1 m36.6 m

Balance sheet & financial health

Fiscal year 2025 · 31 Dec 2025

Cash
189.9 m GBP
Financial debt
764.9 m GBP
Net debt
575.0 m GBP
Equity
914.5 m GBP
Total assets
2.3 bn GBP
Debt / equity
0.84x
Current ratio
1.57x
ROE
-15.5%
ROA
-6.5%
FCF margin
2.1%

Financial statements (source on every figure)

Revenue and net income (GBP)

Margins

Income statement · GBP

Revenue
2023
1.9 bn
2024
1.9 bn
2025
1.7 bn

esef· 12 May 2026verified

Operating income
2023
-39.5 m
2024
-26.2 m
2025
-50.2 m

esef· 12 May 2026verified

Pre-tax income
2023
-110.9 m
2024
-87.6 m
2025
-114.1 m

esef· 12 May 2026verified

Income tax
2023
-6.3 m
2024
-18.6 m
2025
36.0 m

esef· 12 May 2026verified

Net income
2023
-67.0 m
2024
-72.6 m
2025
-157.0 m

esef· 12 May 2026verified

Diluted EPS
2023
-0.79
2024
-0.44
2025
-0.96

esef· 12 May 2026verified

Dividend per share
2023
0.00
2024
0.00
2025
—

esef· 15 Apr 2025derived

Balance sheet · GBP

Cash
2023
371.3 m
2024
225.8 m
2025
189.9 m

esef· 12 May 2026verified

Receivables
2023
213.0 m
2024
227.2 m
2025
153.8 m

esef· 12 May 2026verified

Inventories
2023
344.1 m
2024
348.2 m
2025
336.9 m

esef· 12 May 2026verified

Current assets
2023
950.9 m
2024
826.1 m
2025
689.8 m

esef· 12 May 2026verified

Property, plant & equipment, net
2023
705.7 m
2024
688.5 m
2025
—

esef· 15 Apr 2025verified

Goodwill
2023
465.7 m
2024
455.1 m
2025
443.0 m

esef· 12 May 2026verified

Total assets
2023
2.7 bn
2024
2.5 bn
2025
2.3 bn

esef· 12 May 2026verified

Accounts payable
2023
431.3 m
2024
391.6 m
2025
397.7 m

esef· 12 May 2026verified

Short-term debt
2023
700.0 k
2024
124.2 m
2025
0

esef· 12 May 2026verified

Long-term debt
2023
870.3 m
2024
698.6 m
2025
764.9 m

esef· 12 May 2026verified

Current liabilities
2023
488.1 m
2024
555.1 m
2025
438.1 m

esef· 12 May 2026verified

Total liabilities
2023
1.5 bn
2024
1.4 bn
2025
1.4 bn

esef· 12 May 2026verified

Equity
2023
1.2 bn
2024
1.1 bn
2025
914.5 m

esef· 12 May 2026verified

Shares outstanding at year end
2023
85.4 m
2024
163.5 m
2025
163.5 m

esef· 12 May 2026derived

Cash flow · GBP

Operating cash flow
2023
150.0 m
2024
-33.5 m
2025
124.3 m

esef· 12 May 2026verified

Capex
2023
84.0 m
2024
90.6 m
2025
87.7 m

esef· 12 May 2026verified

Free cash flow
2023
66.0 m ≈
2024
-124.1 m ≈
2025
36.6 m ≈

esef· 12 May 2026derived

Investing cash flow
2023
107.7 m
2024
-61.7 m
2025
-65.0 m

esef· 12 May 2026verified

Financing cash flow
2023
-90.9 m
2024
-45.9 m
2025
-96.8 m

esef· 12 May 2026verified

Dividends paid
2023
0
2024
0
2025
—

esef· 15 Apr 2025verified

Share repurchases
2023
400.0 k
2024
200.0 k
2025
0

esef· 12 May 2026verified

Computed indicators

Growth

Revenue growth (YoY)
-10.0%
computed by olivLawFY 2025
Revenue CAGR 3Y
unavailable
input data missing
Revenue CAGR 5Y
unavailable
input data missing
EBIT growth (YoY)
unavailable
the base of the ratio is not positive
Net income growth (YoY)
unavailable
the base of the ratio is not positive
Net income CAGR 3Y
unavailable
input data missing
Net income CAGR 5Y
unavailable
input data missing
EPS growth (YoY)
unavailable
the base of the ratio is not positive
EPS CAGR 3Y
unavailable
input data missing
EPS CAGR 5Y
unavailable
input data missing
FCF growth (YoY)
unavailable
the base of the ratio is not positive

Profitability

Gross margin
unavailable
input data missing
EBITDA margin
unavailable
input data missing
EBIT margin
-2.9%
computed by olivLawFY 2025
Net margin
-9.0%
computed by olivLawFY 2025
FCF margin
2.1%
computed by olivLawFY 2025

Returns

ROE
-15.8%
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
ROA
-6.5%
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
ROIC
-2.6%
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
ROCE
-2.7%
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
Payout ratio (EPS)
unavailable
insufficient data
Payout ratio (FCF)
0.0%
computed by olivLawFY 2025

Balance sheet

Net debt
575.0 m GBP
computed by olivLawbalance sheet at 31 Dec 2025
Net debt / EBITDA
unavailable
input data missing
Debt / equity
0.8x
computed by olivLawbalance sheet at 31 Dec 2025
Interest coverage
unavailable
input data missing

Liquidity

Current ratio
1.6x
computed by olivLawbalance sheet at 31 Dec 2025
Quick ratio
0.8x
computed by olivLawbalance sheet at 31 Dec 2025
Cash ratio
0.4x
computed by olivLawbalance sheet at 31 Dec 2025

Cash

Operating cash flow
124.3 m GBP
computed by olivLawFY 2025
Capital expenditure
87.7 m GBP
computed by olivLawFY 2025
Free cash flow
36.6 m GBP
computed by olivLawFY 2025
FCF conversion
unavailable
insufficient data
Cash conversion
unavailable
input data missing

Efficiency

Days sales outstanding
40 days
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
Days inventory outstanding
unavailable
input data missing
Days payables outstanding
unavailable
input data missing
Cash conversion cycle
unavailable
input data missing

Market and valuation

Market capitalisation
178.6 m GBP
computed by olivLawbalance sheet at 31 Dec 2025
Enterprise value
753.6 m GBP
computed by olivLawbalance sheet at 31 Dec 2025
Market cap / net income TTM
unavailable
insufficient data
P/E (TTM)
unavailable
insufficient data
Earnings yield
-87.9%
computed by olivLawFY 2025
P/B
0.2x
computed by olivLawbalance sheet at 31 Dec 2025
P/S
0.1x
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
EV/EBITDA
unavailable
input data missing
EV/EBIT
unavailable
insufficient data
EV/Sales
0.4x
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
P/FCF
4.9x
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
FCF yield
20.5%
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
Dividend yield
0.0%
computed by olivLawFY 2025
Shareholder yield (distributions)
0.0%
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025

1 indicators that do not apply to the sector.

Valuation

olivLaw classification

Insufficient data
What is missing
  • score weight coverage: 39.6% of at least 60%
  • valuation methods computed: 0 of at least 1

A scoring methodology on indicators and valuation, not investment advice.

Closing price

1.09 GBP

05 Nov 2026Source: olivLaw, closing series

Market cap: 178.6 m GBP

Key indicators

Market capitalisation
178.6 m GBP
computed by olivLawbalance sheet at 31 Dec 2025
P/E (TTM)
unavailable
insufficient data
P/B
0.2x
computed by olivLawbalance sheet at 31 Dec 2025
EV/EBITDA
unavailable
input data missing
ROE
-15.8%
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
Net margin
-9.0%
computed by olivLawFY 2025
Revenue growth (YoY)
-10.0%
computed by olivLawFY 2025
Dividend yield
0.0%
computed by olivLawFY 2025

Coverage and freshness

28/37 reporting lines present
Latest full fiscal year: 2025
Latest reported period: 31 Dec 2025
Latest balance sheet date: 31 Dec 2025
Share count (cover of the latest filing), as of: 31 Dec 2025
Source: esefpublished 12 May 2026
verified 83derived 5

Score by group

40% · Insufficient data

Estimated value range

unavailable — no valuation assumptions for the reporting currency

Valuation assumptions are editorial choices, not measured; beta is not measured.

Valuation methods

    Assumptions (illustrative, editorial)

    Risk-free rate
    6.5%
    Equity risk premium
    6.0%
    Beta (default)
    1.00
    Cost of equity
    12.5%
    Terminal growth
    3.0%

    Factor scorecard

    Insufficient data

    Minimum-evidence gate: score weight coverage: 39.6% of at least 60%; valuation methods computed: 0 of at least 1

    FactorValueScoreWeight used
    ROIC · Quality-2.6%17 (vs peers)26%
    Net margin · Quality-9.0%23 (vs peers)16%
    FCF conversion · Qualityunavailableunavailable—
    Revenue CAGR 3Y · Growthunavailableunavailable—
    EPS CAGR 3Y · Growthunavailableunavailable—
    Net debt / EBITDA · Balance sheetunavailableunavailable—
    Interest coverage · Balance sheetunavailableunavailable—
    Current ratio · Balance sheet1.6x65 (on a fixed band)11%
    P/E (TTM) · Valuationunavailableunavailable—
    EV/EBITDA · Valuationunavailableunavailable—
    FCF yield · Valuation20.5%100 (on a fixed band)21%
    Shareholder yield (distributions) · Returns0.0%0 (on a fixed band)16%
    Payout ratio (FCF) · Returns0.0%100 (on a fixed band)11%

    Factors without a value were dropped; the remaining weights were renormalised.

    Score groups

    • Balance sheet· partial65/100 · 1/3 factors with a value
    • Growth· partialunavailable · 0/2 factors with a value
    • Quality19/100 · 2/3 factors with a value
    • Returns40/100 · 2/2 factors with a value
    • Valuation· partial100/100 · 1/3 factors with a value

    A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.

    Memo

    SYNTHOMER PLC (SYNT.L). Latest full fiscal year: 2025; data up to 2025-12-31.

    Figures computed from the financial statements: revenue 1.7 bn GBP in 2025; YoY growth -10.0%; net margin -9.0%; ROE -15.8%.

    Valuation cannot be computed from the available data.

    Insufficient data for a verdict (score weight coverage: 39.6% of at least 60%; valuation methods computed: 0 of at least 1).

    Text generated deterministically from the figures shown; no language model. Not investment advice.

    What supports the thesis

    • FCF yield: 20.5%
    • Payout ratio (FCF): 0.0%

    What contradicts it

    • ROIC: -2.6%
    • Net margin: -9.0%
    • Shareholder yield (distributions): 0.0%

    Not assessed (insufficient data or a ratio without meaning): FCF conversion, Revenue CAGR 3Y, EPS CAGR 3Y, Net debt / EBITDA, Interest coverage, P/E (TTM), EV/EBITDA.

    Versus the vertical median

    Listed companies from United Kingdom · same country · compared with 39 companies

    Multiples and returns vs the median

    P/E
    —
    vertical median 15.3x
    EV/EBITDA
    —
    vertical median —
    P/S
    0.1x
    vertical median 1.5x
    below median (−93.3%)
    P/B
    0.2x
    vertical median 2.2x
    below median (−90.8%)
    ROE
    -15.8%
    vertical median 14.4%
    below median (−209.6%)
    Net margin
    -9.0%
    vertical median 10.8%
    below median (−183.8%)
    EBIT margin
    -2.9%
    vertical median 22.9%
    below median (−112.6%)
    Revenue YoY
    -10.0%
    vertical median 7.9%
    below median (−227.3%)
    Net debt/EBITDA
    —
    vertical median —
    Dividend yield
    0.0%
    vertical median 2.9%
    below median (−100.0%)

    Price rebased to 100 (monthly, 5 years)

    Companies in the vertical

    Market capP/EROENet marginRevenue YoY1A / 3A
    BATS.LBritish American Tobacco P.L.C.104.3 bn13.516.5%30.3%−1.0%+7% / +88%
    ABF.LAssociated British Foods PLC14.7 bn14.39.2%5.3%−3.1%−5% / −15%
    0EV1.LCarnival PLC5.5 bn4.146.7%13.4%+6.4%unavailable / unavailable
    BAB.LBabcock International Group PLC5.1 bn24.734.7%4.1%+7.2%−10% / +158%
    AUTO.LAutotrader Group PLC4.8 bn16.460.2%47.1%+3.9%−13% / −23%
    BBY.LBalfour Beatty PLC4.2 bn16.323.2%2.8%+15.2%+20% / +160%
    ABDN.LAberdeen Group PLC4.1 bn10.88.0%28.9%−2.1%+11% / +41%
    BKG.LThe Berkeley Group Holdings PLC3.6 bn11.38.8%13.4%−4.2%−0% / −22%
    BME.LB&M European Value Retail PLC2.9 bn17.421.2%2.8%+3.7%+68% / −51%
    AJB.LAj Bell PLC2.4 bn22.849.9%33.1%+18.0%+8% / +128%
    ASHM.LAshmore Group PLC1.4 bn13.913.1%71.6%−0.1%+28% / +18%
    BCG.LBaltic Classifieds Group PLC1.2 bn23.215.8%57.6%+6.9%−99% / −99%
    APN.LApplied Nutrition PLC763.6 m36.241.2%19.7%+24.2%+71% / unavailable
    BAG.LA.G. Barr P.L.C.671.9 m14.414.4%10.8%+4.0%−7% / +26%
    ASC.LAsos PLC494.5 m—-81.3%-12.0%−14.7%+71% / +8%
    ALFA.LAlfa Financial Software Holdings PLC486.8 m16.361.5%23.8%+15.3%−28% / +10%
    AML.LAston Martin Lagonda Global Holdings PLC344.3 m—-93.4%-39.2%−20.6%−45% / −85%
    SYNT.LSynthomer PLC178.6 m—-15.8%-9.0%−10.0%+73% / −37%
    APTD.LAptitude Software Group PLC111.3 m28.57.2%6.2%−7.3%−30% / −23%
    AMGO.LAmigo Holdings PLC9.9 m———−81.9%+325% / +844%
    ASBE.LAssociated British Engineering PLC605.3 k—-19.1%—unavailableunavailable / unavailable
    AMIF.LAmicorp Fs (uk) PLC221.6 k0.127.5%9.1%+8.1%unavailable / unavailable
    AAF.LAirtel Africa PLC——24.1%10.6%+29.5%−7% / +164%
    AAL.LAnglo American PLC——-19.3%-20.2%+4.5%+30% / +76%
    ACG.LAcg Metals Limited——-80.3%-32.0%+134.8%+60% / +63%

    1- and 3-year price returns: for SYNT.L from daily closes (the same as the performance table), for the other companies from month-end closes.

    olivLaw engine forecast

    The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.

    The engine has no published run for this company yet.

    Valuation scenarios (editable assumptions)

    Illustrative scenarios

    Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.

    Bear
    Allowed range: -50 … 50%
    Allowed range: -100 … 100%
    Allowed range: 0 … 100
    Allowed range: -10 … 20%
    Allowed range: 0 … 100%
    Base
    Allowed range: -50 … 50%
    Allowed range: -100 … 100%
    Allowed range: 0 … 100
    Allowed range: -10 … 20%
    Allowed range: 0 … 100%
    Bull
    Allowed range: -50 … 50%
    Allowed range: -100 … 100%
    Allowed range: 0 … 100
    Allowed range: -10 … 20%
    Allowed range: 0 … 100%
    Nothing is saved.

    Estimated price (GBP)

    Estimated priceBearBaseBull
    1 years
    insufficient data
    Total return unavailable · Per year unavailable
    insufficient data
    Total return unavailable · Per year unavailable
    insufficient data
    Total return unavailable · Per year unavailable
    3 years
    insufficient data
    Total return unavailable · Per year unavailable
    insufficient data
    Total return unavailable · Per year unavailable
    insufficient data
    Total return unavailable · Per year unavailable
    5 years
    insufficient data
    Total return unavailable · Per year unavailable
    insufficient data
    Total return unavailable · Per year unavailable
    insufficient data
    Total return unavailable · Per year unavailable
    What moves the 3-year price the most

      AI analysis

      AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

      In brief

      Synthomer is a speciality chemicals producer supplying water-based polymers and ingredients to business customers in coatings, construction, adhesives and health markets. The company is working through weak demand, but its specialisation strategy and cost programmes have lifted margins and cash flow, while debt remains a central focus, with revenue of £1,739.2m and net debt of £575.0m in fiscal 2025 1.

      SWOT

      Strengths

      • A portfolio tilted towards speciality products and a broad base of long-standing customers 1.
      • A multi-region production network and innovation capability backed by dedicated centres 1.
      • Positive cash generation in fiscal 2025 and cost programmes that supported margins 1.

      Weaknesses

      • Lower revenue and volumes in fiscal 2025, with dependence on weak end markets 1.
      • High net debt that limits financial flexibility and requires further leverage reduction 1.
      • Margins remain weak in some businesses, such as medical gloves and acrylate monomers 1.

      Opportunities

      • A rising share of speciality and sustainability-led products could improve margins if customer adoption grows 1.
      • Technology and commercial partnerships, including in China and bio-based polymers, could open new markets 1.
      • A recovery in end-market demand could support volume growth and operating leverage 1.

      Threats

      • Tariff and geopolitical uncertainty may continue to delay customer purchasing decisions 1.
      • Capacity expansion in Asia could intensify price competition 1.
      • Supply chain disruption and volatility in energy or raw materials could affect deliveries 1.

      Risks

      • Failure to deliver strategic initiativesmedium

        Missing transformation targets, talent management and M&A activity could delay the strategic plan 1.

      • Demand and competitive dynamicshigh

        Growth in existing markets and entry into new ones is uncertain in a volatile environment with pressure from new capacity 1.

      • Innovation and intellectual propertymedium

        Adapting products and protecting intellectual property are essential to keeping competitive advantage 1.

      • Supply chain disruptionmedium

        Security of energy, raw materials and logistics can be affected by external factors, which could disrupt deliveries 1.

      • Financial position and debthigh

        Reducing net debt remains a priority, and financial markets and the balance sheet may limit the company's room for manoeuvre 1.

      Investment thesis

      What would need to be true (bull case)

      • If end-market demand recovers, operating leverage in speciality activities could support a significant improvement in margins and cash flow 1.
      • Cost programmes and divestments could strengthen the balance sheet and reduce debt, supporting greater financial flexibility 1.
      • A higher share of speciality and sustainability-led products could lead to a stronger position in higher value-added markets 1.

      What would break the thesis

      • If demand stays weak and tariffs keep discouraging customers, revenue and volumes could remain under pressure 1.
      • High net debt and financial covenants may limit the company's ability to invest and respond to market changes 1.
      • Capacity expansion in Asia could intensify competition and press prices, affecting margins 1.

      What to watch

      • Progress in reducing net debt towards the medium-term leverage target2026
      • Delivery of the additional cost benefits announced for 20262026
      • Progress of the four divestment processes under way2026

      Products, market & competition

      AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

      The business

      Synthomer creates high-performance water-based polymers and ingredients for customers across several end markets, organised in the Coatings & Construction Solutions, Adhesive Solutions and Health & Protection and Performance Materials divisions 1. The company describes itself as a speciality chemicals producer focused on selected end markets and says its innovation and technical service support long-standing relationships with more than 6,000 customers 1. In fiscal 2025 it operates 29 manufacturing sites across the Americas, EMEA and Asia, with a target of 25 or fewer 1.

      Since 2022 Synthomer has been reshaping its portfolio towards more speciality products, a more balanced geographic mix and a simpler structure. Divestments and plant closures have reduced complexity, and speciality businesses reached 55% of revenues 1. The company reported positive Free Cash Flow in fiscal 2025 after an outflow in the prior year 1.

      The corporate centre remains small and focuses on business excellence, risk management, capital allocation and portfolio management 1. If the reduction of debt towards the medium-term target is achieved, financial flexibility could improve, although the plans depend on end-market volume growth 1.

      Segments

      Coatings & Construction Solutions

      The CCS division serves coatings, construction, energy and consumer sub-segments, and demand varied in fiscal 2025 after global tariff changes 1. The company noted a slightly improved coatings trend towards year-end, offset by weaker construction and consumer demand 1.

      Adhesive Solutions

      Adhesive Solutions regained share and improved margins through reliability and performance programmes, and speciality capacity investment in Texas supports growth 1. The division also works on sustainability partnerships with customers such as Henkel 1.

      Health & Protection and Performance Materials

      HPPM had a mixed year: medical glove volumes were disappointing with margins still well below pre-pandemic levels, while Speciality Vinyl Polymers made a relatively strong contribution 1. Acrylate monomers remained a challenge 1.

      Market context

      Synthomer's end markets are affected by prolonged weak demand in the chemicals sector, and trade and geopolitical uncertainty led customers to delay decisions in fiscal 2025 1. The company says capacity expansion in China and Asia may intensify competition 1. Speciality products and those with sustainability benefits are seen as the main long-term growth drivers 1.

      The company links its long-term markets to megatrends such as urbanisation, demographic change and sustainability, but the pace of demand recovery remains uncertain 1. If end-market volumes grow, Synthomer could benefit from operating leverage in its most specialised activities 1.

      Trends

      • Weak demand and tariff uncertaintyheadwind

        Volumes fell in fiscal 2025 due to soft demand and customer caution over tariffs and geopolitics, which weighed on revenue 1.

      • Cost reduction through self-help programmestailwind

        Self-help programmes and the removal of around 250 roles can support margins if demand stays weak 1.

      • Shift towards speciality and sustainable productstailwind

        A higher share of speciality and sustainability-led products could add value, but it requires investment and time 1.

      • Balance sheet strengtheningmixed

        Reducing debt through divestments and cash generation is a priority, but progress depends on market conditions and transactions not yet completed 1.

      Competitive position

      Synthomer faces competition in speciality chemicals, where growing capacity in China and Asia could pressure prices and share 1. The company also points to structural changes in base chemicals that are reshaping the competitive landscape 1.

      Synthomer's stated advantages are innovation, technical service, supply chain flexibility and production close to customer markets, which could support its position in speciality segments 1.

      • Speciality and polymer chemicals producers (not named in source)

        The source does not name specific competitors; the company refers only to general competitive pressure from Asia and changes in base chemicals 1.

      • Capacity producers in China and Asia

        Capacity expansion in the region is cited as a competitive pressure factor, without naming companies 1.

      • Base chemicals producers

        The company mentions structural shifts in base chemicals that change competition, without naming firms in the given source 1.

      • Glove and medical polymer suppliers

        The medical glove market is affected by weaker volumes and margins, and competitors are not identified in the source 1.

      News & filings

      In the press

      No news in our archive over the last 180 days.

      Annual reports (ESEF)

      Sources

      1. [1] Annual report, fiscal year ended 2025-12-31 (ESEF) · SEC / Synthomer plc · 31 Dec 2025

      Figures computed by olivLaw from ESEF annual reports and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.